Stephen M Simes insider trades: Biosante Pharmaceuticals (BPAX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stephen reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 18, 2011 | BPAX | ↑ Buy | 5,000 | $1.77 | $9K | By Trust | Jan 19, 2011 (1d) |
| Jan 2, 2009 | BPAX | ↑ Buy | 10,000 | $1.09 | $11K | By Trust | Jan 5, 2009 (3d) |
| Dec 14, 2007 | BPAX | ↑ Buy | 10,000 | $3.70 | $37K | By Trust | Dec 17, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Stephen M Simes's insider trades
Stephen M Simes is Vice Chairman, President & CEO at Biosante Pharmaceuticals (BPAX). Since Dec 14, 2007, Stephen has reported 3 open-market purchases worth $57K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), option exercises (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BPAX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.